FY2025 · ended Dec 31, 2025 · Revenue $115.02M, -38.1% YoY · Filed Mar 9, 2026
Orasure Technologies, Inc (OSUR) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $115.0 million and a net loss of $68.7 million. Free cash flow was -$53.2 million. As of Jun 30, 2026 it held $160.6 million in cash and investments and $12.1 million in total debt.
Revenue (TTM)
$112.41M
-18.9% vs year-ago TTM
Net income (TTM)
$-49.13M
+3.7% vs year-ago TTM
Operating cash flow (TTM)
$-42.88M
-149.8% vs year-ago TTM
Free cash flow (TTM)
$-48.06M
-138.9% vs year-ago TTM
EPS (TTM)
$-0.69
-1.5% vs year-ago TTM
Dividend per share
None
Shares outstanding
69.13M
-7.6% vs prior year
Net cash
$148.49M
as of Jun 30, 2026
Operating margin
-48.1%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- OSUR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Bethlehem, PA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1116463
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $115.0M | $185.8M | $405.5M | $387.5M | $233.7M |
| Operating income | -$72.0M | -$28.2M | $32.7M | -$22.2M | -$10.2M |
| Net income | -$68.7M | -$19.5M | $53.7M | -$17.1M | -$23.0M |
| Diluted EPS | -$0.94 | -$0.26 | $0.72 | -$0.24 | -$0.32 |
| Operating cash flow | -$49.0M | $27.4M | $141.6M | -$47.2M | -$35.4M |
| Free cash flow | -$53.2M | $23.6M | $135.8M | -$54.0M | -$57.3M |
| Total assets | $403.2M | $479.7M | $482.8M | $444.2M | $461.0M |
| Total liabilities | $62.3M | $69.3M | $52.2M | $79.8M | $80.5M |
| Stockholders' equity | $340.8M | $410.3M | $430.7M | $364.4M | $380.5M |
| Cash and investments | $199.3M | $267.8M | $290.4M | $110.8M | $170.1M |
| Total debt | $13.2M | $14.6M | $13.5M | $12.5M | $12.3M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 8-K |
Current report
Other events
|
Jun 11, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 3, 2026 | Jun 3, 2026 |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 6, 2026 | May 6, 2026 |
All 1000 Orasure Technologies, Inc SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.